Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2011
[A case of encephalopathy that was suspected to be caused by chemotherapy for colon cancer]Hideaki Ganno, Keiichi Fujiya, Masahiro Nakamura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2011
[A case report of esophageal carcinoma developing esophago-brochial fistula successfully treated by esophageal bypass surgery]Takeshi Nagahama, Masayuki Ando, Keiichi Fujiya, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 26, 2016
Early detection of nonperitoneal recurrence may contribute to survival benefit after curative gastrectomy for gastric cancerKeiichi Fujiya, Masanori Tokunaga, Rie Makuuchi, et al.
Digestive Diseases and Sciences|November 28, 2013
Different gastric mucosa and CagA status of patients in India and Japan infected with Helicobacter pyloriKeiichi Fujiya, Naoyoshi Nagata, Tomohisa Uchida, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 10, 2017
The value of diagnostic endoscopic submucosal dissection for patients with clinical submucosal invasive early gastric cancerKeiichi Fujiya, Kohei Takizawa, Masanori Tokunaga, et al.
Anticancer Research|October 30, 2024
A Gene Expression Signature that Predicts Gastric Cancer Sensitivity to PARP Inhibitor TherapyKeiichi Fujiya, Masakuni Serizawa, Keiichi Ohshima, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 19, 2020
Prediction of S-1 adjuvant chemotherapy benefit in Stage II/III gastric cancer treatment based on comprehensive gene expression analysisKenichi Nakamura, Keiichi Hatakeyama, Kenichiro Furukawa, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 23, 2020
MAGEA10 expression is a predictive marker of early hepatic recurrence after curative gastrectomy for gastric and gastroesophageal junction cancerKeiichi Fujiya, Masanori Terashima, Keiichi Ohshima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[A case of gastric cancer accompanied by disseminated carcinomatosis of the bone marrow successfully controlled by S-1 and cisplatin combination therapy]Hideaki Ganno, Takeshi Nagahama, Akira Fukuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 27, 2012
[Hepatic arterial infusion with subsequent hepatectomy for a sigmoid colon cancer patient with hepatic metastases-a case report]Masayuki Ando, Toshiaki Kurokawa, Hideaki Ganno, et al.
Pageof 8